Clinical Trial Update: Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BCD-089 in combination with methotrexate for active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BCD-089
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Biocad | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED